Common Contracts

EX-2.6 6 a2230492zex-2_6.htm EX-2.6 Form of INTELLECTUAL PROPERTY LICENSE AGREEMENT between BIOGEN INC. and BIOVERATIV INC. Dated as of [·],[·] Page

Intellectual Property License Agreement • May 5th, 2020 • Delaware

• Contract Type
  Intellectual Property License Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

Form of INTELLECTUAL PROPERTY LICENSE AGREEMENT between BIOGEN INC. and BIOVERATIV INC.

Intellectual Property License Agreement • December 20th, 2016 • Bioverativ Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Intellectual Property License Agreement
• Filed
  December 20th, 2016
• Company
  Bioverativ Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

Form of INTELLECTUAL PROPERTY LICENSE AGREEMENT between BIOGEN INC. and BIOVERATIV INC.

Intellectual Property License Agreement • November 29th, 2016 • Bioverativ Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Intellectual Property License Agreement
• Filed
  November 29th, 2016
• Company
  Bioverativ Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This INTELLECTUAL PROPERTY LICENSE AGREEMENT (this “Agreement”) is made and effective as of [ ], 2017 (the “Effective Date”) by and between Bioverativ Inc. (“Bioverativ”), a Delaware corporation, and Biogen Inc. (“Biogen”), a Delaware corporation (each of Bioverativ and Biogen being a “Party,” and collectively, the “Parties”).